WHO WE ARE
Asia is colorful
and full of opportunity. However, navigating these diverse markets can also be complicated, resource intensive and frustrating without strong local knowledge and infrastructure.
Everlife invests strategically in distribution companies in the region with the aim to provide customers with more complete and advanced medical and laboratory solutions in areas where it matters.
Our Partners
Chemopharm
Leading SEA provider of products, solutions and services for laboratory and analytical testing, life science and healthcare.
DV Medika
Manufacturer of one of Indonesia’s top brands of hospital furniture and distributor of sophisticated medical devices.
Biorev
Distributor of scientific bench-top equipment, consumables, custom services, chemical and biological reagents for the life sciences industry.
CPC
The leading Indian manufacturer and distributor of clinical diagnostic solutions across a wide range of applications
Supplying physicians, researchers and industry professionals with the world’s most trusted brands
LATEST NEWS
Everstone invests in Chemopharm, a leading Southeast Asian distributor of medical products and solutions
Singapore, November 23, 2017 – The Everstone Group via its platform Everlife has acquired Malaysia-based Chemopharm Sdn Bhd., a leading provider of products and services’ solutions to laboratory, research and medical facilities in Southeast Asia. Singapore-based Cure Capital is a co-investor, along with Everstone.
Everstone-backed Everlife invests in Chennai based CPC Diagnostics
Mumbai, March 13, 2019 – The Everstone Group via its healthcare platform Everlife has acquired a stake in Chennai based CPC Diagnostics, to include core in-vitro diagnostics (IVD) segments in its portfolio of medical devices and extend its geographical presence to India, with this first investment in the country.